Skip to main content
Log in

Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ajello L: Soil as natural reservoir for human pathogenic fungi. Science 1956, 123: 876–879.

    Google Scholar 

  2. Cooke WB, Kabler P: Isolation of potentially pathogenic fungi from polluted water and sewage. Public Health Reports 1955, 70: 689–694.

    Google Scholar 

  3. Hung CC, Chang SC, Yang PC, Hsieh WC: Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 749–751.

    Google Scholar 

  4. Travis LB, Roberts GD, Wilson WR: Clinical significance ofPseudallescheria boydii: a review of 10 years' experience. Mayo Clinic Proceedings 1985, 60: 531–537.

    Google Scholar 

  5. Lutwick LI, Galgiani JN, Johnson RH, Stevens DA: Visceral fungal infections due toPetriellidium boydii: (Allescheria boydii). In vitro drug susceptibility studies. American Journal of Medicine 1976, 61: 632–640.

    Google Scholar 

  6. Ruxin TA, Steck WD, Helm TN, Bergfeld WF, Bolwell BJ:Pseudallescheria boydii in an immunocompromised host. Successful treatment with débridement and itraconazole. Archives of Dermatology 1996, 132: 382–384.

    Google Scholar 

  7. Stolk-Engelaar MVM, Cox NJM: Successful treatment of pulmonary pseudallescheriasis with itraconazole. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 142.

    Google Scholar 

  8. Goldberg SL, Geha DJ, Marshall WF, Inwards DJ, Hoagland HC: Successful treatment of simultaneous pulmonaryPseudallescheria boydii andAspergillus fumigatus infection with oral itraconazole. Clinical Infectious Diseases 1993, 16: 803–805.

    Google Scholar 

  9. Petranyi G, Meingassner JG, Mieth H: Antifungal activity of the allylamine derivate terbinafine in vitro. Antimicrobial Agents and Chemotherapy 1987, 31: 1365–1368.

    Google Scholar 

  10. Shadomy S, Espinell-Ingroff A, Gebhart RJ: In vitro studies with SF 86-327, a new orally active allylamine derivate. Sabouraudia 1985, 23: 125–132.

    Google Scholar 

  11. Galgiani JN, Stevens DA, Graybill JR, Stevens DL, Tillinghast AJ, Levine HB:Pseudallescheria boydii infections treated with ketoconazole. Chest 1984, 86: 219–224.

    Google Scholar 

  12. Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA: Activities of amphotericin B and antifungal azoles alone and in combination againstPseudallescheria boydii. Antimicrobial Agents and Chemotherapy 1995, 39: 1361–1364.

    Google Scholar 

  13. Villars VV, Jones TC: Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. British Journal of Dermatology 1992, 126, Supplement 39: 61–69.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verweij, P.E., Cox, N.J.M. & Meis, J.F.G. Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy. Eur. J. Clin. Microbiol. Infect. Dis. 16, 26–28 (1997). https://doi.org/10.1007/BF01575117

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01575117

Keywords

Navigation